Published in News
We are delighted to present this 2023/24 report on the activities and achievements of the Global Alliance for Chronic Diseases (GACD).
Message from Chief Executive
A year in which we are excited to be able to share the impact of our research more widely at major international events including the World Congress in NCDs in Toronto.
GACD remains a unique alliance of international funders and researchers at the forefront of delivering impactful implementation research that can inform current and future prevention and management of the huge global burden of chronic non communicable disease. In this last year, we were excited to announce the outcomes of our 8th joint call for proposals, with 16 excellent international collaborative projects involving 24 countries/institutions focused on reducing NCD risk factors in underserved urban populations.
Together, the GACD funding agencies have invested more than US$38 million to make meaningful progress in addressing non-communicable diseases (NCDs) in some of the most underserved urban communities across the world.
Importantly in this year the GACD Strategy Board initiated a ‘refresh’ of our Strategic Plan for 2025-2030, in recognition of accelerated world change and impacts on NCDs. The Board invited a group of diverse, outstanding, international experts in chronic NCDs, implementation research, multi-sector working, community outreach, and policymaking to help guide our future research priorities. Their insights and recommendations have paved the way for an early announcement on our next three research call themes.
GACD also successfully convened its Annual Scientific Meeting 2023 in Singapore. This meeting served as a platform for fruitful discussions, knowledge exchange, and the forging of new collaborations, further advancing our collective efforts to address NCDs on a global scale. I am delighted that the ASM this year has resulted in the creation of three new working and special interest groups.
I extend my gratitude to our international funding agencies, associate members, and the members of the GACD Research Network, and of course my dynamic team for their time and collective energy to ensure the research we support is productive and likely to have tangible impact.
Dr. Morven Roberts
CEO, Global Alliance for Chronic Diseases